We have previously shown that treatment of neonatal human articular-cartilage proteoglycan aggregates with H202 results in loss of the ability of the proteoglycan subunits to interact with hyaluronic acid and in fragmentation of the link proteins [Roberts, Mort & Roughley (1987) Biochem. J. 247, 349-357]. We now show the following. (1) Hyaluronic acid in proteoglycan aggregates is also fragmented by treatment with H202. (2) Although H202 treatment results in loss of the ability of the proteoglycan subunits to interact with hyaluronic acid, the loss of this function is not attributable to substantial cleavage of the hyaluronic acidbinding region of the proteoglycan subunits. (3) In contrast, link proteins retain the ability to bind to hyaluronic acid following treatment with H202. (4) The interaction between the proteoglycan subunit and link protein is, however, abolished. (5) N-Terminal sequence analysis of the first eight residues of the major product of link protein resulting from H202 treatment revealed that cleavage occurred between residues 13 and 14, so that the new N-terminal amino acid is alanine. (6) In addition, a histidine (residue 16) is converted into alanine and an asparagine (residue 21) is converted into aspartate by the action of H202. (7) Rat link protein showed no cleavage or modifications in similar positions under identical conditions. (8) This species variation may be related to the different availability of histidine residues required for the co-ordination of the transition metal ion involved in hydroxyl-radical generation from H202. (9) Changes in function of these structural macromolecules as a result of the action of H202 may be consequences of both fragmentation and chemical modification.
INTRODUCTION
The proteoglycan aggregates of human articular cartilage are composed of proteoglycan subunits in non-covalent associations with hyaluronic acid. These associations are stabilized further by the link proteins, which bind to both the proteoglycan subunit and hyaluronic acid. The mechanical functioning of cartilage is thought to depend on the retention of proteoglycans in the tissue, and this in turn is believed to depend upon the ability of these molecules to form aggregates of high Mr. The proteoglycan content of an aggregate is a function of the length of its hyaluronic acid filament and of the continued ability of proteoglycan subunits and link proteins to interact with each other and with hyaluronic acid.
There is considerable interest in the mechanisms by which proteoglycan aggregates may be modified, particularly concerning the action of proteinases upon the aggregates (reviewed by Muir, 1980) . More recently, it has been proposed that reactive oxygen metabolites may also be involved in the degradation of connective tissue that occurs under inflammatory arthritic conditions and in disorders involving excessive deposition of transition metal ions in the joint, such as haemophilia and Wilson's disease (reviewed by Halliwell & Gutteridge, 1984 .
The production of partially reduced metabolites of oxygen is a consequence of normal aerobic metabolism (Chance et al., 1979) . In addition, phagocytic cells are capable of producing larger amounts of reactive oxygen metabolites at their surfaces during the oxidative burst. These metabolites have been shown to be able to activate (Weiss et al., 1985) or inactivate proteinases and to inactivate proteinase inhibitors (Vissers & Winterbourn, 1987) under appropriate experimental conditions. A number of studies have demonstrated the ability of reactive oxygen metabolites to degrade proteoglycans directly (Bartold et al., 1984; Bates et al., 1984; Chung et al., 1984; Dean et al., 1984 ), and we have described in detail some structural modifications that occur in neonatal human articular-cartilage proteoglycan aggregates as a result of treatment with H202 (Roberts et al., 1987) . These modifications include fragmentation of the link proteins and loss of the ability of proteoglycan monomers to associate with hyaluronic acid, despite minimal decrease in subunit size. We site of cleavage and two amino acid modifications that occur in the N-terminal region of the link protein, the relative lack of fragmentation within the hyaluronic acid-binding region of the proteoglycan subunits and the degradation of hyaluronic acid within the aggregate.
MATERIALS AND METHODS

Materials
Guanidinium chloride and trypsin (tosylphenylalanylchloromethane-treated) were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. CsCl was from Accurate Chemical and Scientific Co., Westbury, NY, U.S.A. Materials for electrophoresis were from Bio-Rad Laboratories, Toronto, Ont., Canada. Poly(vinylidene difluoride) transfer membranes were from Millipore Corp. Bedford, MA, U.S.A. H202 was AnalaR grade (30°/, v/v) from BDH Chemicals, Toronto, Ont., Canada. Radiochemicals were from Amersham International, Mississauga, Ont., Canada. Rabbit anti-(mouse IgG1) antibody was from SciCan Diagnostics, Edmonton, Alberta, Canada, and the reagents for hyaluronic acid assay (HA Test 50) were kindly provided as a kit by Pharmacia Diagnostics A.B., Uppsala, Sweden. All solutions were made up freshly in water of resistance greater than 10 MQ/cm, purified by using a Millipore MilliQ water-purification system. Methods Preparation of proteoglycan aggregate. Neonatal human articular cartilage was obtained at autopsy within 18 h of death and extracted in 4 M-guanidinium chloride/0. 1 M-sodium acetate buffer, pH 6.0, containing 1 mm each of EDTA, phenylmethanesulphonyl fluoride and iodoacetic acid and 1 ag of pepstatin/ml (Roughley & White, 1980) . The extracts were dialysed to associative conditions (Roughley et al., 1982) , adjusted to a starting density of 1.5 g/ml by the addition of CsCl and centrifuged at 100000 gay, for 48 h at 10°C in a fixedangle rotor. The proteoglycan aggregates were isolated from the lower part of the gradient (density greater than 1.55 g/ml), dialysed twice against water, once against 0.1 M-potassium acetate and exhaustively against water and then freeze-dried. On analysis by Sepharose CL-2B chromatography, 7000 of the proteoglycan was shown to be in aggregate form.
Rat chondrosarcoma proteoglycan aggregate was prepared by an identical procedure after harvesting the Swarm chondrosarcoma from Sprague-Dawley rats that had been injected subcutaneously with a chondrosarcoma-cell suspension (Oegema et al., 1975) .
Reaction of proteoglycan aggregates with H202 Proteoglycan aggregates were dissolved at 3 mg/ml in 25 mM-sodium acetate buffer, pH 5.6, containing 80 mMNaCl, and 200 pl portions of this solution were routinely used for experiments. Experimental additions of appropriate dilutions of H202 were made in a volume of 10 1d to produce the desired final concentrations, which were in the range 0-240 mM-H202. Reactions were allowed to proceed for 24 h at 37°C, and the samples then dialysed against 0.125 M-Tris/HCI buffer, pH 6.8.
Treatment of proteoglycan aggregates with trypsin. Proteoglycan aggregates were treated with trypsin, following treatment with H202, in the following manner. The samples were dialysed against 0.1 M-Tris/HCI buffer, pH 7.5, and trypsin was added to a final concentration of 10 tg/mg of proteoglycan aggregate. The samples were incubated at 37°C for 4 h, then phenylmethanesulphonyl fluoride was added to a final concentration of 1 mm, and the samples were dialysed against 0.1 M-Tris/HCI buffer, pH 6.8, before electrophoresis.
Analytical CsCI -density -gradient centrifugation. Analysis of the ability of components of the proteoglycans to interact was performed by CsCl-densitygradient centrifugation under associative conditions with starting densities of 1.45 or 1.69 g/ml, after determining that these conditions allow the differentiation of link protein interaction in the form of proteoglycan aggregate from link protein interacting with hyaluronic acid alone ( Fig. 1) . CsCl was added to samples of treated proteoglycan solution to produce the desired final density, and 240,u1 portions of these solutions were centrifuged at 150000gmax. for 24 h in a Beckman Airfuge (Rostand et al., 1982) . It was determined that the interactions between the components of the proteoglycan aggregate were stable in these procedures. At the end of the centrifugation, tube contents were fractionated into three 80 ,tl fractions, 10 Ijl of each fraction was assayed for uronic acid by the carbazole method of Bitter & Muir (1962) , and the remainder was dialysed against 0.1 MTris/HCl, pH 6.8, before electrophoresis.
Electrophoresis and Western blotting. SDS/polyacrylamide-gel electrophoresis was performed in 1000 slab gels under the conditions described by Laemmli (1970) . Sample preparation, electrophoresis and Western-blot analysis were essentially as previously described (Roberts et al., 1987) . All samples were heated in the presence of 5 00 (v/v) 2-mercaptoethanol before being loaded on to the gels. Proteins were electroblotted on to nitrocellulose membranes in 2000 (v/v) methanol/ 15.6 mM-Tris/ 120 mM-glycine buffer, pH 8.3.
The membranes were blocked in 1 % (w/v) bovine haemoglobin in 0.145 M-NaCl/ 10 mM-sodium/potassium phosphate buffer, pH 7.8, containing 0.050 NaN3 before incubation with ascitic fluids, which contained monoclonal antibodies as required. These were 9/30/8-A-4 (Caterson et al., 1985a,b) , which recognizes two nearly identical epitopes in intact link protein (Neame et al., 1986) , and 12/20/2-A-5, which recognizes an epitope close to the hyaluronic acid-binding region of the core protein of the proteoglycan (Caterson et al., 1985a) . Both of these antibodies were kindly supplied by Dr. Bruce Caterson, Department of Biochemistry, University of West Virginia, Morgantown, WV, U.S.A. The monoclonal antibody 12/20/2-A-5, which is of the IgGI subclass, was localized by the use of a second-step rabbit anti-(mouse IgGl) antibody. The nitrocellulose membranes were incubated with monoclonal antibodies as required, and regions of antibody binding were located by the use of 125I protein A as previously described (Roberts et al., 1987) .
Sepharose CL-2B chromatography. Before chromatography samples were reduced and alkylated. Guanidinium chloride was added to each sample to a final concentration of 4 M, dithiothreitol was added to a final concentration of 5 mm, and the samples were then incubated at 40°C for 5 h. lodoacetamide was added to a final concentration of 20 mm, and the samples were incubated at 40°C for I h and then overnight at 4 'C. All samples were then extensively dialysed against water before being chromatographed on a 11O cm x 1 cm column of Sepharose CL-2B at a flow rate of 6 mI/h in 50 mM-Tris/HCI buffer, pH 7.3, containing 4 Mguanidinium chloride. Each sample contained 1.5 mg of proteoglycan in 1 ml. Fractions (1 ml) were monitored for uronic acid by the carbazole method of Bitter & Muir (1962) , or for glycosaminoglycans by the Dimethylmethylene Blue dye-binding assay (Farndale et al., 1986) , which was standardized with chondroitin sulphate.
Hyaluronic acid assay. Column fractions were assayed for hyaluronic acid by the radiometric method of Tengblad (1980) . The principle of this assay is that hyaluronic acid in the test sample binds to added 1251-labelled hyaluronic acid-binding protein, and unbound 125I-labelled hyaluronic-acid-binding protein is quantified by its binding to hyaluronic acid that is covalently linked to Sepharose beads. The assay was performed under the conditions suggested by Pharmacia, and was standardized with reduced and alkylated neonatal human cartilage proteoglycan and with standard solutions of rooster comb hyaluronic acid that were furnished by Pharmacia.
Purification and sequencing analysis of link proteins. Proteoglycan aggregates were treated with 60 mM-H202 as above, or untreated. They were then dialysed extensively, first against 0.1 M-Tris/HCI buffer, pH 6.8, and then against 0.2 M-sodium acetate buffer, pH 5.5. Guanidinium chloride was then added to a final concentration of 4 M, and CsCI to a final density of 1.5 g/ml. The link proteins were then isolated from the proteoglycans by CsCl-density-gradient centrifugation at 100000 g in a fixed-angle rotor at 10°C, dialysed extensively against 0.1 M-Tris/HCI buffer, pH 6.8, and concentrated by ultrafiltration on an Amicon YM5 membrane. The link proteins were then separated by electrophoresis, electroblotted on to poly(vinylidene difluoride) membranes and stained with Coomassie (Roberts et al., 1987) , indicating that only minimal degradation was occurring under these conditions. The presence and integrity of the hyaluronic acid-binding region of the proteoglycan subunits in these preparations was therefore studied to determine whether free radicals were causing its cleavage in a manner analogous to the initial action of proteinases. (Fig. 3) proteins and proteoglycans (Fig. 4) , which can only be hyaluronic acid (see Fig. 1 ). Thus, not only is the interaction between the proteoglycan subunit and hyaluronic acid impaired by H202 treatment, but also that between the proteoglycan subunit and link protein.
In contrast, the interaction between link protein and hyaluronic acid remains functional.
Analysis of the effects of H202 treatment upon hyaluronic acid Proteoglycans were incubated in the absence or in the presence of 120 mM-H202, then reduced and alkylated under dissociative conditions and chromatographed on Sepharose CL-2B (Fig. 5) The first observable change in neonatal human link protein on treatment with H202 is the complete conversion of the 48000-and 44000-Mr components into a band migrating to a similar position on SDS/polyacrylamide gels to the minor 41 000-Mr component. The sequence of the first eight amino acid residues of this H202-generated component was determined (Fig. 6 ). When compared with the sequences of the naturally occurring 48000-, 44000-and 41 OOO-Mr molecules (Nguyen et al., 1989) , which were determined on link proteins from the same individual, the H202-generated link protein was observed to start at residue 14 of the 48000-or 44000-Mr molecules and was distinct from the 41 000-Mr molecule. In addition, the conversion of two of the first eight amino acid residues to other residues was observed in the H202-generated link protein: alanine for histidine at residue 3 and aspartate for asparagine at residue 8. These results indicate that both peptide-bond cleavage and amino acid modification may occur as a consequence of free-radical attack. (Nguyen et al., 1989) . (c) Human link protein, Mr 41000 (Nguyen et al., 1989) . (d) Rat chondrosarcoma link protein (Neame et al., 1986) . Amino acid residues in boldface type represent differences due to H202 treatment, and amino acid residues underlined represent differences between the human and rat sequences.
DISCUSSION
In our previous study (Roberts et al., 1987) al., 1987) and the proteoglycan subunits (Neame et al., 1987 Cleavage within the N-terminal region of the link protein occurs between residues 13 and 14. Interestingly, histidine occurs at residues 11 and 16, and this amino acid has been implicated in the chelation of the transition metal ions necessary to participate in the conversion of H202 into the hydroxyl radical. Localization of protein modifications to the vicinity of histidine residues may be a result of chelation of transition-metal ions by this amino acid pair and the generation of a more reactive metabolite of oxygen occurring in a reaction between H202 and the transition-metal ion. This reactant is postulated to react very closely to its site of generation, and may be a complexed form of the hydroxyl radical (Bors et al., 1979; Samuni et al., 1981; Sutton et al., 1987) . In support of this hypothesis is the observation that similar treatment does not result in cleavage of the rat chondrosarcoma link protein, which contains glutamine rather than histidine at residue 11, and therefore might not chelate transition metal ions tightly in this region.
Earlier studies (Creeth et al., 1983; Cooper et al., 1985) , using amino acid analysis, showed loss of histidine residues following H202 treatment of ovarian-cyst mucus glycoproteins and cleavage of a synthetic polyhistidine 
